Answers are grounded in this paper and cite their sources.
Whereas anti-PD-(L)1 therapies are widely used in cancer treatment, only a subset of patients achieve long-term survival. Companion diagnostics based on PD-L1 expression have limited predictive power for these therapies, motivating development of additional predictive markers. We demonstrate a digital pathology (DP) method to quantify the density and epithelial infiltration of cytotoxic T cells near the tumor epithelial–stromal interface (ESI) using pancytokeratin-CD8 immunohistochemistry slides. We used POPLAR ( n = 188), a phase 2 clinical trial of atezolizumab vs. docetaxel in previously treated non-small cell lung cancer, to train a machine learning outcome prediction model, generating a novel score, the Digital Assessment of Cytotoxic T cell Infiltration (DACTI). DACTI correlated with bulk RNAseq signatures of immune infiltration, providing verification that the DP measurements captured genuine aspects of the tumor microenvironment. A greater concentration of CD8 + T cells at the ESI and greater infiltration of those cells into the tumor epithelium were associated with benefit from atezolizumab, but not docetaxel. We validated DACTI in OAK ( n = 879), a randomized phase 3 trial with treatment arms identical to POPLAR. Atezolizumab-treated DACTI-high patients in the validation set had longer overall survival than docetaxel-treated patients ( n = 337, hazard ratio [HR] = 0.67, 95% confidence interval [CI]: 0.53–0.86; treatment interaction Cox model p -value = 0.028), including in patients with PD-L1 negative tumors ( n = 61, HR = 0.47, 95% CI:0.27–0.84). This difference between arms was not observed in the DACTI-low group ( n = 518, HR = 0.94, 95%CI: 0.78–1.13). These results suggest that automated analysis of pathology images may be able to direct immunotherapy treatments to patients who will most benefit.
No takes yet. Share an insight, caveat, or question.
Leo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: